Home Healthcare Biotechnology Cancer Genetic Testing Market

Cancer Genetic Testing Market Size, Share & Trends Analysis Report By Type (Cytogenetic Testing/Chromosome Analysis, Biochemical Testing, Molecular Testing, DNA Sequencing), By Application (Lung Cancer, Cervical Cancer, Ovarian Cancer, Prostate Cancer, Breast Cancer, Uterine Cancer), By End-Users (Hospitals and Clinics, Clinical Labs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Cancer Genetic Testing Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Cytogenetic Testing/Chromosome Analysis
    2. Biochemical Testing
    3. Molecular Testing
    4. DNA Sequencing
  2. Cancer Genetic Testing Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Lung Cancer
    2. Cervical Cancer
    3. Ovarian Cancer
    4. Prostate Cancer
    5. Breast Cancer
    6. Uterine Cancer
  3. Cancer Genetic Testing Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Clinical Labs
  4. Regional Cancer Genetic Testing Market
    1. North America
      1. North America Cancer Genetic Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
      2. North America Cancer Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Cervical Cancer
        3. Ovarian Cancer
        4. Prostate Cancer
        5. Breast Cancer
        6. Uterine Cancer
      3. North America Cancer Genetic Testing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Clinical Labs
      4. U.S.
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      5. Canada
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
    2. Europe
      1. Europe Cancer Genetic Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
      2. Europe Cancer Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Cervical Cancer
        3. Ovarian Cancer
        4. Prostate Cancer
        5. Breast Cancer
        6. Uterine Cancer
      3. Europe Cancer Genetic Testing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Clinical Labs
      4. U.K.
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      5. Germany
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      6. France
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      7. Spain
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      8. Italy
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      9. Russia
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      10. Nordic
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      11. Benelux
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      12. Rest of Europe
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
    3. APAC
      1. APAC Cancer Genetic Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
      2. APAC Cancer Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Cervical Cancer
        3. Ovarian Cancer
        4. Prostate Cancer
        5. Breast Cancer
        6. Uterine Cancer
      3. APAC Cancer Genetic Testing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Clinical Labs
      4. China
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      5. Korea
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      6. Japan
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      7. India
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      8. Australia
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      9. Singapore
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      10. Taiwan
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      11. South East Asia
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      12. Rest of Asia-Pacific
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
    4. Middle East and Africa
      1. Middle East and Africa Cancer Genetic Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
      2. Middle East and Africa Cancer Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Cervical Cancer
        3. Ovarian Cancer
        4. Prostate Cancer
        5. Breast Cancer
        6. Uterine Cancer
      3. Middle East and Africa Cancer Genetic Testing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Clinical Labs
      4. UAE
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      5. Turkey
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      6. Saudi Arabia
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      7. South Africa
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      8. Egypt
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      9. Nigeria
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      10. Rest of MEA
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
    5. LATAM
      1. LATAM Cancer Genetic Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
      2. LATAM Cancer Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Cervical Cancer
        3. Ovarian Cancer
        4. Prostate Cancer
        5. Breast Cancer
        6. Uterine Cancer
      3. LATAM Cancer Genetic Testing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Clinical Labs
      4. Brazil
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      5. Mexico
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      6. Argentina
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      7. Chile
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      8. Colombia
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
      9. Rest of LATAM
        1. Cytogenetic Testing/Chromosome Analysis
        2. Biochemical Testing
        3. Molecular Testing
        4. DNA Sequencing
        5. Lung Cancer
        6. Cervical Cancer
        7. Ovarian Cancer
        8. Prostate Cancer
        9. Breast Cancer
        10. Uterine Cancer
        11. Hospitals and Clinics
        12. Clinical Labs
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.